HHE Sponsored supplement: Sepsis | Page 8

‘view into the future’, especially concerning the major impact of this disease for the economic burden as well as for the medical threats worldwide. immature neutrophils) are fulfilled. Merely ten years after the consensus conference hosted by Bone et al, 5 several experts then met in Washington to discuss a new definition of sepsis. A classification system allowing stratification of septic patients, termed PIRO (today called Sepsis-2), was developed at this conference in 2001. 6 (P stands for predisposition; I, for type and extent of the primary insult (in the case of sepsis, primary infection); R, for type and extent of host response; and O, for extent of organ dysfunction). The introduction of a PIRO model, however, remained theoretical, even though there have been several attempts to introduce a system that enables scoring of septic patients. 7 In an approximately two-year process with extended and complex biometric evaluations, a new approach called Sepsis-3 was developed, which is based on patient data from several validated sources, and which was published in the form of three papers in 2016. 8–10 A key element of this concept is the omission of SIRS as a factor in the definition of sepsis. The new Sepsis-3 defines sepsis as: “a life-threatening organ dysfunction caused by a dysregulated host response to infection”. 8 Therefore, if no organ dysfunction is seen, one may only speak of an infection, not of sepsis. The term severe sepsis is superfluous as its criteria (organ failure) are already included in the new definition of sepsis. The term septic shock remained but now includes an elevated lactate level >2mmol/l as an additional factor. This short overview, which is far from being fully comprehensive, demonstrates that it is not easy to compare epidemiological data of sepsis. In the following, this dilemma should be kept in mind, and simple comparisons of large data sets, that are based on different definitions and/or selection criteria for sepsis, should be performed with care. 100 years of varying definitions A teleological definition was proposed by Hugo Schottmüller in 1914: “Sepsis is present if a focus has developed from which pathogenic bacteria constantly or periodically, invade the bloodstream in such a way that this causes subjective and objective symptoms”. 4 This definition is problematic and increasingly being dismissed, as it is based on subjective clinical observations. In addition, it insinuates an incorrect pathophysiological rationale as it assumes that bacteria themselves spread. However, today one assumes that the body produces its own transmitters as a response to the infection and that these spread systemically, thus affecting peripheral organs. 3 Partly due to these arguments, a US surgeon, Roger Bone, organised a conference in which consensus was reached that sepsis should be defined with tangible criteria and should, therefore, include the aspect of host response. Here, the term systemic inflammatory response syndrome (SIRS), which is still commonly used, was defined. 5 If SIRS occurs without infection (for example, burns, pancreatitis, post-operative setting, etc), the condition is only defined as SIRS; similarly, an infection without SIRS does not equal sepsis. Only when infection in combination with SIRS are observed may one speak of sepsis. Therefore, sepsis was defined as “a systemic inflammatory response syndrome to infection” that may be seen when two or more of the four SIRS criteria (heart rate >90/min; core temperature >38°C or <36°C; respiratory rate >20/min or PaCO 2 <32mmHg; white blood cell count >12,000/ml or <4000/ml or >10% Research versus administration At first glance, it might be simpler to gather data from administrative hospital files than trying to obtain prospective data from research protocols. However, both ways contain tricks and traps that must be considered. Example 1 (research) In a prospective, multicentre, longitudinal observational study, a total of 11,883 patients from 133 ICUs at 95 German hospitals over four weeks were included. The patients were followed up for the occurrence of severe sepsis or septic shock (Sepsis-1 definitions) during their ICU stay. 11 A total of 1503 patients (12.6%) with severe sepsis or septic shock were diagnosed. The calculated incidence rate of severe sepsis or septic shock was 11.64 per 1000 ICU days. ICU mortality in patients with severe sepsis/septic shock was 34.3%, compared with 6% in those without sepsis. Total hospital mortality of patients with severe sepsis or septic shock was 40.4%. Classification of the septic shock patients using the new Sepsis-3 definitions showed higher ICU and hospital mortality (44.3 and 50.9%, respectively). 11 Example 2 (administration) To determine the incidence and mortality of sepsis and septic shock, German case-related 8 HHE 2018 | hospitalhealthcare.com